Parkinsons Disease With Dementia (PDD) Completed Phase 2 Trials for Blarcamesine (DB05592)

Also known as: Dementia Parkinson's Disease / Parkinson Disease Dementia / Parkinson Disease-Dementia / Parkinson's Disease Dementia / Parkinson Disease Dementia (PDD) / Parkinson's Disease Dementia (PDD) / Parkinson's Disease With Dementia / Parkinsons Disease With Dementia / Dementia With Parkinson's Disease / Parkinson Disease With Dementia

IndicationStatusPhase
DBCOND0122035 (Parkinsons Disease With Dementia (PDD))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04575259OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001Treatment
NCT03774459ANAVEX2-73 Study in Parkinson's Disease DementiaTreatment